Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Leukemia 17Breast Neoplasms 14Rectal Neoplasms 7Neoplastic Cells, Circulating 7Lung Neoplasms 7Leukemia, Myeloid, Acute 7Colorectal Neoplasms 7Colonic Neoplasms 7Prostatic Neoplasms 6Head and Neck Neoplasms 6Kidney Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Congenital Abnormalities 4Wilms Tumor 3Neoplasms, Plasma Cell 3Carcinoma, Renal Cell 3Carcinoma, Intraductal, Noninfiltrating 3Unspecified Adult Solid Tumor, Protocol Specific 2Ovarian Neoplasms 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Esophageal Neoplasms 2Endometrial Neoplasms 2

Interventions

Sunitinib 145Nivolumab 143pembrolizumab 132Sorafenib 84Bevacizumab 77Everolimus 74cabozantinib 70pazopanib 65Axitinib 65Ipilimumab 62aldesleukin 52Magnetic Resonance Spectroscopy 45Cyclophosphamide 40Interleukin-2 38lenvatinib 37Specimen Handling 36Radiosurgery 36Interferon-alpha 32atezolizumab 29temsirolimus 27belzutifan 24Gemcitabine 23fludarabine phosphate 22avelumab 22Radiotherapy 19Interferon alpha-2 19Biopsy 18fludarabine 17durvalumab 17Nephrectomy 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00747305 2015-10-22

Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery

Medical University of South Carolina

Phase 1 Terminated
17 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00589550 2015-06-08

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase 1 Terminated
1 enrolled 2 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01158534 2012-08-07

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Case Comprehensive Cancer Center

Phase 2 Completed
17 enrolled 9 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡